Studies in mice on the mutagenicity of two contraceptive drugs.
- 1 June 1979
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 16 (3) , 206-209
- https://doi.org/10.1136/jmg.16.3.206
Abstract
An experiment is described which tests for visible and invisible mutants in mice treated with four different doses each of the contraceptives Gynanovlar and Lyndiol. The results show that there is no reason to suppose that either substance has an appreciable mutagenic effect, expressed as an increase of antenatal and postnatal lethals or visibles. The substrain CBA/CagCam, used throughout, has an incidence of 0.27% of singly occurring abnormalities, mainly of the appendicular skeleton, which distinguishes it from the parent CBA strain and its axial variation described by Gruneberg (1963).This publication has 18 references indexed in Scilit:
- Oral contraceptives and amino acid utilizationAmerican Journal of Obstetrics and Gynecology, 1970
- Cytogenetic studies on women using oral contraceptives and their progenyPublished by Elsevier ,1970
- CHROMOSOMES AND AN ORAL CONTRACEPTIVE (LYNDIOL 2{middle dot}5)Reproduction, 1969
- Meiotic Chromosome Alterations produced by ProgesteroneNature, 1968
- Effects of Contraceptive Steroids on Carbohydrate MetabolismJournal of Clinical Endocrinology & Metabolism, 1968
- Cytological effects of two contraceptivesGenetica, 1967
- The overall rates of dominant and recessive lethal and visible mutation induced by spermatogonial X-irradiation of miceGenetics Research, 1964
- Drugs Used in Control of ReproductionPublished by Elsevier ,1964
- The estimation of mutation rates from incompletely tested gametes, and the detection of mutations in mammalsJournal of Genetics, 1949
- Accuracy of mutation ratesJournal of Genetics, 1942